Vivtex is enabling the development of new oral drugs for medications that currently require painful, inconvenient needle injections using its high-throughput, gut-on-a-chip platform supported by its proprietary AI algorithms and formulations.

Cooler Heads provides cancer patients and care providers with FDA-cleared products, content, and services for the management of side effects of treatment.

Moody improves mental and physical health for women by connecting their hormone health data with actionable support.

Culina Health is democratizing access to insurance reimbursed clinical nutrition sessions with a licensed registered dietitian.

RevivBio uses ultrahigh throughput experimentation and generative machine learning to design better proteins with greater efficiency and success.

Phinomics is a novel, data-driven platform that unlocks previously hidden circular DNA biomarkers and addresses unmet needs in precision medicine.

TRIPP is building a self-directed, fully immersive XR platform to help individuals seeking personal transformation or assistance with mental health issues by designing and curating neuroscientific-based digital wellness psychedelic experiences.

EV Biotech creates Microbial Cell factories using cutting-edge computational modeling technology to provide industries with effective production methods. This is done faster, better, and cheaper by using our EEVEE pipeline consisting of proprietary computer algorithms to evaluate millions of strategies and can precisely tailor the cell to client requirements.

MarPam Pharma is developing a revolutionary one-time HIV treatment that equips a patient's own immune cells with the ability to seek out and destroy HIV where it hides, thus eliminating the burdensome need for daily medications.

Shiru leverages machine learning and precision biology to identify functional, nutritious, and sustainable protein ingredients. Shiru aims to create sustainable food solutions that future-proof our food supply by leveraging high-tech solutions.

Sardona Therapeutics is a preclinical biotechnology company building the leading platform to develop small molecule drugs that target RNA-binding proteins in the spliceosome, and provide patients with therapy-resistant cancers novel treatment options. Sardona is advancing a robust pipeline of multiple, internally-developed programs, including the lead program, that has particular activity in mTORC1-pathway activated breast cancers and other solid tumor indications.

SiDx is modernizing blood testing using patented silicon photonic biosensors and specialized surface chemistry that returns blood typing results in a fraction of the time. SiDx’s innovation conserves universal blood units and speeds turnover for overcrowded emergency departments.

At Stratyfy, we are on a mission to accelerate financial inclusion by providing greater visibility and less bias to critical financial decisions that impact millions of people. Stratyfy delivers a growing suite of proprietary machine learning products for financial institutions and fintechs, optimizing credit risk assessment and fraud detection while minimizing risk and mitigating bias. With Stratyfy, companies can optimize their decisions and reduce bias to serve more customers and drive better business outcomes.